Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Tuesday, April 28, 2015 10:45:27 PM
bullish
## source: finance.yahoo.com
Tue, 28 Apr 2015 10:22:00 GMT ~ 6:22 am Novogen regains full compliance with Nasdaq listing rule
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#nvgn
*********************************************************
Tue, 28 Apr 2015 03:48:00 GMT ~ Novogen Regains Full Compliance with NASDAQ Listing Rule
[PR Newswire] - NASDAQ: NVGN) (Company), announced today that it received a letter from NASDAQ informing it that it had regained full compliance with NASDAQ Listing Rule 5550(b) (Listing Rule).
read full: http://finance.yahoo.com/news/novogen-regains-full-compliance-nasdaq-034800625.html
*********************************************************
Mon, 27 Apr 2015 04:15:00 GMT ~ Novogen Posts Details on Rights Issue Offering for Shareholders
[PR Newswire] - NVGN: NASDAQ) (Company), announced last week that it lodged a prospectus with ASIC on 23 April 2015 relating to its pro rata non-renounceable rights issue (Offering). The prospectus has been posted on its website and notices to shareholders and optionholders have been dispatched as required under the ASX Listing Rules. Copies of the notices to shareholders and optionholders are available on the Company's website at www.novogen.com. This announcement intends to bring certain key matters and important dates to the attention of shareholders and to the market generally.
read full: http://finance.yahoo.com/news/novogen-posts-details-rights-issue-041500151.html
*********************************************************
Wed, 22 Apr 2015 02:27:00 GMT ~ Cantrixil Receives Orphan Drug Designation from FDA
[PR Newswire] - SYDNEY, April 21, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today announced that its subsidiary joint venture company with Yale University, CanTx, Inc, has today received notification from the U.S. Food and Drug Administration (FDA) that its chemotherapy candidate drug, Cantrixil, has been granted Orphan Drug Designation for ovarian cancer. Orphan Drug Designation is an important development for any experimental drug and has been instigated in a number of territories including the U.S, Europe and Australia to encourage the development of drugs for clinical indications that do not have a high incidence.
read full: http://finance.yahoo.com/news/cantrixil-receives-orphan-drug-designation-022700141.html
*********************************************************
Tue, 21 Apr 2015 15:52:00 GMT ~ Novogen (NVGN) Stock Falls Today on Private Placement
read full: http://www.thestreet.com/story/13120383/1/novogen-nvgn-stock-falls-today-on-private-placement.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
$NVGN charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$NVGN company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NVGN/company-info
Ticker: $NVGN
OTC Market Place: Not Available
CIK code: 0001075880
Company name: Novogen Ltd.
Company website: http://www.novogen.com
Incorporated In: Australia
$NVGN share structure
## source: otcmarkets.com
Market Value: $510,992 a/o Apr 27, 2015
Shares Outstanding: 2,018,137 a/o Jan 03, 2011
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$NVGN extra dd links
Company name: Novogen Ltd.
Company website: http://www.novogen.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NVGN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NVGN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NVGN+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/news - http://finance.yahoo.com/q/h?s=NVGN+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NVGN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NVGN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NVGN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Novogen+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Novogen+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Novogen+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.novogen.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.novogen.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.novogen.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NVGN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001075880&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NVGN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NVGN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NVGN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NVGN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NVGN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NVGN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NVGN+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NVGN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NVGN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NVGN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NVGN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NVGN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NVGN/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NVGN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NVGN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NVGN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NVGN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NVGN
$NVGN DD Notes ~ http://www.ddnotesmaker.com/NVGN
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM